Prevention of type 2 diabetes: what is the right target population?

References

• American Heart Association. Understand Your Risk for Diabetes 2018 [ cited 2018 Sep 09]; Available from: http://www.heart.org/en/health-topics/diabetes/understand-your-risk-for-diabetes
   Google Scholar
• Centers for Disease Control and Prevention. Who’s at Risk? 2018 [ cited 2018 Sep 09]; Available from: https://www.cdc.gov/diabetes/basics/risk-factors.html
   Google Scholar
• National Institute of Diabetes and Digestive and Kidney Diseases. Risk Factors for Type 2 Diabetes 2018 [ cited 2018 Sep 09]; Available from: https://www.niddk.nih.gov/health-information/diabetes/overview/risk-factors-type-2-diabetes
   Google Scholar
• Mainous AG 3rd, Tanner RJ, Jo A, et al. Prevalence of prediabetes and abdominal obesity among healthy-weight adults: 18-year trend. Ann Fam Med. 2016 Jul;14(4):304–310. PubMed PMID: 27401417; PubMed Central PMCID: PMCPMC4940459.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014 May 7;311(17):1778–1786. PubMed PMID: 24794371; PubMed Central PMCID: PMCPMC4368900.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Stafford JM, Mayer-Davis EJ, et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017 Feb 28;317(8):825–835. PubMed PMID: 28245334; PubMed Central PMCID: PMCPMC5483855.
   PubMed Web of Science ®Google Scholar
• Ali O. Genetics of type 2 diabetes. World J Diabetes. 2013 Aug 15;4(4):114–123. . PubMed PMID: 23961321; PubMed Central PMCID: PMCPMC3746083.
   PubMedGoogle Scholar
• Kato N. Insights into the genetic basis of type 2 diabetes. J Diabetes Investig. 2013 May 6;4(3):233–244. . PubMed PMID: 24843659; PubMed Central PMCID: PMCPMC4015657.
   PubMed Web of Science ®Google Scholar
• Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016 May 20;17(5). PubMed PMID: 27213358; PubMed Central PMCID: PMCPMC4881593. doi:10.3390/ijms17050774.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007 May;30(5):1212–1218. PubMed PMID: 17277038.
   PubMed Web of Science ®Google Scholar
• Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J Gastroenterol. 2014 Jul 21;20(27):9072–9089. . PubMed PMID: 25083080; PubMed Central PMCID: PMCPMC4112878.
   PubMed Web of Science ®Google Scholar
• Bril F, Cusi K. Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care. 2017 Mar;40(3):419–430. . PubMed PMID: 28223446.
   PubMed Web of Science ®Google Scholar
• Liu M, Wang J, Zeng J, et al. Association of NAFLD with diabetes and the impact of BMI changes: a 5-year cohort study based on 18,507 elderly. J Clin Endocrinol Metab. 2017 Apr 1;102(4):1309–1316. PubMed PMID: 28324002.
   PubMed Web of Science ®Google Scholar
• Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015 Jun 18;7(11):1450–1459. . PubMed PMID: 26085906; PubMed Central PMCID: PMCPMC4462685.
   PubMed Web of Science ®Google Scholar
• Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015 Apr;4(2):101–108. . PubMed PMID: 26005676; PubMed Central PMCID: PMCPMC4405411.
   PubMed Web of Science ®Google Scholar
• Lazo M, Solga SF, Horska A, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010 Oct;33(10):2156–2163. PubMed PMID: 20664019; PubMed Central PMCID: PMCPMC2945152.
   PubMed Web of Science ®Google Scholar
• Mazza AD, Pratley RE, Smith SR. Beta-cell preservation…is weight loss the answer? Rev Diabet Stud. 2011 Winter;8(4): 446–453, PubMed PMID: 22580726; PubMed Central PMCID: PMCPMC3359689.
   PubMedGoogle Scholar
• Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003 Mar;26(3):725–731. PubMed PMID: 12610029.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosing Diabetes and Learning about Prediabetes 2018 [ cited 2018 Sep 09]; Available from: http://www.diabetes.org/diabetes-basics/diagnosis/
   Google Scholar
• Khavandi K, Amer H, Ibrahim B, et al. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis. 2013 Sep;4(5):242–261. 10.1177/2040622313494986. PubMed PMID: 23997928; PubMed Central PMCID: PMCPMC3752182.
   PubMedGoogle Scholar
• The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb;3466:393–403. . PubMed PMID: 11832527; PubMed Central PMCID: PMCPMC1370926. eng.
   PubMed Web of Science ®Google Scholar
• Perreault L, Kahn SE, Christophi CA, et al. Regression from prediabetes to normal glucose regulation in the Diabetes Prevention Program. Diabetes Care. 2009 Sep;32(9):1583–1588. PubMed PMID: 19587364; PubMed Central PMCID: PMCPMC2732165.
   PubMed Web of Science ®Google Scholar
• Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program outcomes study. Lancet. 2012 Jun 16;379(9833):2243–2251. PubMed PMID: 22683134; PubMed Central PMCID: PMCPMC3555407.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Abdul-Ghani MA. Preservation of beta-cell function: the key to diabetes prevention. J Clin Endocrinol Metab. 2011 Aug;96(8):2354–2366. . PubMed PMID: 21697254
   PubMed Web of Science ®Google Scholar
• Gillett M, Royle P, Snaith A, et al. Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess. 2012 Aug;16(33):1–236, iii–iv. PubMed PMID: 22935084; PubMed Central PMCID: PMCPMC4780928.
   PubMed Web of Science ®Google Scholar
• Defronzo RA, Tripathy D, Schwenke DC, et al. Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes. 2013 Nov;62(11):3920–3926. PubMed PMID: 23863810; PubMed Central PMCID: PMCPMC3806596.
   PubMed Web of Science ®Google Scholar
• Phung OJ, Sood NA, Sill BE, et al. Oral anti-diabetic drugs for the prevention of type 2 diabetes. Diabet Med. 2011 Aug;28(8):948–964. PubMed PMID: 21429006.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Statistics about Diabetes 2013 [ cited 2017 Aug 17]; Available from: http://www.diabetes.org/diabetes-basics/statistics/
   Google Scholar
• Zhuo X, Zhang P, Barker L, et al. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014 Sep;37(9):2557–2564. PubMed PMID: 25147254.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States. 2014.
   Google Scholar
• Obesity Society. Your weight and diabetes 2015 [ cited 2017 aug 17]; Available from: http://www.obesity.org/content/weight-diabetes
   Google Scholar
• Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol. 2012 Apr;49(2):89–95. . PubMed PMID: 21720880.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. PubMed PMID: 3056758.
   PubMed Web of Science ®Google Scholar
• The Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999 Apr;22(4):623–634. PubMed PMID: 10189543; PubMed Central PMCID: PMCPMC1351026. eng.
   PubMed Web of Science ®Google Scholar
• Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care. 1997 Apr;20(4):537–544. PubMed PMID: 9096977.
   PubMed Web of Science ®Google Scholar
• The Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 Dec;25(12):2165–2171. PubMed PMID: 12453955; PubMed Central PMCID: PMCPMC1282458. eng.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 03;344(18):1343–1350. PubMed PMID: 11333990.
   PubMed Web of Science ®Google Scholar
• Williamson DA, Martin CK, Stewart TM. Behavioral strategies for controlling obesity. In: Bray GA, Ryan DH, editors. Overweight and the metabolic syndrome: from bench to bedside. New York: Springer; 2007. p. 219–232.
   Google Scholar
• Jensen MD, Ryan DH, Donato KA, et al. Guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014;22(S2):S1–S410.
   PubMedGoogle Scholar
• Williamson DA, Bray GA, Ryan DH. Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? Obesity. Silver Spring. 2015Dec;23(12):2319–2320. PubMed PMID: 26523739
   PubMed Web of Science ®Google Scholar
• Bright R, Sakurada B A Population Health Strategy for Diabetes: New Partners, New Opportunities. 2016.
   Google Scholar
• Tuomilehto J, Schwarz P, Lindström J. Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care. 2011 May;34(Suppl 2):S210–S214. . PubMed PMID: 21525457; PubMed Central PMCID: PMCPMC3632163. eng.
   PubMedGoogle Scholar
• Martin CK, Miller AC, Thomas DM, et al. Efficacy of SMART Loss, a smartphone-based weight loss intervention: results from a randomized controlled trial. Obesity. (Silver Spring). 2015May;23(5);935–942 PubMed PMID: 25919921; PubMed Central PMCID: PMCPMC4414058
   PubMed Web of Science ®Google Scholar
• Omada Health. 2016. Available from: https://www.omadahealth.com/
   Google Scholar
• Weigh and Win. 2016. Available from: http://www.weighandwin.com/
   Google Scholar
• Williamson DA. Fifty years of behavioral/lifestyle interventions for overweight and obesity: where have we been and where are we going? Obesity. (Silver Spring). 2017Nov;25(11):1867–1875. PubMed PMID: 28944593
   PubMed Web of Science ®Google Scholar
• Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003 Oct;24(5):610–628. PubMed PMID: 14500058.
   PubMedGoogle Scholar
• Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014 Jan;221:5–13. . PubMed PMID: 24307184; PubMed Central PMCID: PMCPMC3904491. eng.
   PubMed Web of Science ®Google Scholar
• Look Ahead Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145–154. PubMed PMID: 23796131; PubMed Central PMCID: PMCPMC3791615.
   PubMed Web of Science ®Google Scholar
• Wing RR, Lang W, Ta W, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011 Jul;34(7):1481–1486. PubMed PMID: 21593294; PubMed Central PMCID: PMCPMC3120182.
   PubMed Web of Science ®Google Scholar
• Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012 Dec 19;308(23):2489–2496. PubMed PMID: 23288372; PubMed Central PMCID: PMCPMC4771522.
   PubMed Web of Science ®Google Scholar
• Redmon JB, Bertoni AG, Connelly S, et al. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010 Jun;33(6):1153–1158. PubMed PMID: 20332353; PubMed Central PMCID: PMCPMC2875414.
   PubMed Web of Science ®Google Scholar
• Espeland MA, Glick HA, Bertoni A, et al. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care. 2014 Sep;37(9):2548–2556. PubMed PMID: 25147253; PubMed Central PMCID: PMCPMC4140155.
   PubMed Web of Science ®Google Scholar
• Rejeski WJ, Ip EH, Bertoni AG, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012 Mar 29;366(13):1209–1217. PubMed PMID: 22455415; PubMed Central PMCID: PMCPMC3339039.
   PubMed Web of Science ®Google Scholar
• Rubin RR, Wadden TA, Bahnson JL, et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care. 2014 Jun;37(6):1544–1553. PubMed PMID: 24855155; PubMed Central PMCID: PMCPMC4030096.
   PubMed Web of Science ®Google Scholar
• Williamson DA, Rejeski J, Lang W, et al. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009 Jan 26;169(2):163–171. PubMed PMID: 19171813; PubMed Central PMCID: PMCPMC2705948.
   PubMedGoogle Scholar
• Araghi MH, Chen YF, Jagielski A, et al. Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep. 2013 Oct 1;36(10):1553–62, 1562A-1562E. PubMed PMID: 24082315; PubMed Central PMCID: PMCPMC3773205.
   Web of Science ®Google Scholar
• Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the sleep AHEAD study. Arch Intern Med. 2009 Sep 28;169(17):1619–1626. PubMed PMID: 19786682; PubMed Central PMCID: PMCPMC2879275.
   PubMedGoogle Scholar
• Bennett PH. The Look AHEAD study: a missed opportunity. Lancet Diabetes Endocrinol. 2014 Oct;2(10):775–776. . PubMed PMID: 25282081.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Bahnson JL, Bantle JP, et al. The Look AHEAD study: a missed opportunity–authors’ reply. Lancet Diabetes Endocrinol. 2014 Oct;2(10):776. PubMed PMID: 25282083.
   Web of Science ®Google Scholar
• American Diabetes Association. Obesity management for the treatment of type 2 diabetes. Diabetes Care. 2016 Jan;39(Suppl 1):S47–S51. PubMed PMID: 26696681.
   PubMedGoogle Scholar
• Williamson DA, Perrin LA. Behavioral therapy for obesity. Endocrinol Metab Clin North Am. 1996 Dec;25(4):943–954. PubMed PMID: 8977054; eng.
   PubMed Web of Science ®Google Scholar
• Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care. 2010 Sep;33(9):1957–1959. . PubMed PMID: 20573755; PubMed Central PMCID: PMCPMC2928342.
   PubMed Web of Science ®Google Scholar
• LeFevre ML, Force USPST. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014Oct21;161(8):587–593. PubMed PMID: 25155419
   PubMed Web of Science ®Google Scholar
• Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017 Mar;1391(1):85–100. . PubMed PMID: 27723940.
   PubMed Web of Science ®Google Scholar
• Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009 Feb 26;360(9):859–873. PubMed PMID: 19246357; PubMed Central PMCID: PMCPMC2763382.
   PubMed Web of Science ®Google Scholar
• Ravussin E, Redman LM, Rochon J, et al. A 2-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1097–1104. PubMed PMID: 26187233; PubMed Central PMCID: PMCPMC4841173.
   PubMed Web of Science ®Google Scholar
• Rochon J, Bales CW, Ravussin E, et al. Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):97–108. PubMed PMID: 20923909; PubMed Central PMCID: PMCPMC3032519.
   PubMed Web of Science ®Google Scholar
• Martin CK, Bhapkar M, Pittas AG, et al. Effect of calorie restriction on mood, quality of life, sleep, and sexual function in healthy nonobese adults: the CALERIE 2 randomized clinical trial. JAMA Intern Med. 2016 Jun 1;176(6):743–752. PubMed PMID: 27136347; PubMed Central PMCID: PMCPMC4905696.
   PubMed Web of Science ®Google Scholar
• Romashkan SV, Das SK, Villareal DT, et al. Safety of two-year caloric restriction in non-obese healthy individuals. Oncotarget. 2016 Apr 12;7(15):19124–19133. PubMed PMID: 26992237; PubMed Central PMCID: PMCPMC4991370.
   PubMedGoogle Scholar
• American Association of Clinical Endocrinologists, American College of Endocrinology. Consensus statement by the American association of clinical endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm–2016 executive summary. Endocr Pract. 2016 Jan;22(1):84–113. PubMed PMID: 26731084; eng.
   PubMed Web of Science ®Google Scholar
• Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015 Aug;38(8):1567–1582. PubMed PMID: 26421334; PubMed Central PMCID: PMCPMC4831905.
   PubMed Web of Science ®Google Scholar
• International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009 Jul;32(7):1327–1334. PubMed PMID: 19502545; PubMed Central PMCID: PMCPMC2699715.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Diabetes Prevention Recognition Program 2015 [ cited 2017 Mar 27]; Available from: https://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf
   Google Scholar
• Centers for Medicare and Medicaid Services. Medicare Diabetes Prevention Program Expansion 2016 [ cited 2017 Mar 27]; Available from: http://cms.gov
   Google Scholar
• Waugh NR, Shyangdan D, Taylor-Phillips S, et al. Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technol Assess. 2013 Aug;17(35):1–90. PubMed PMID: 23972041; PubMed Central PMCID: PMCPMC4780946.
   PubMed Web of Science ®Google Scholar
• Schwartz SS, Epstein S, Corkey BE, et al. the time is right for a new classification system for diabetes: rationale and implications of the beta-cell-centric classification schema. Diabetes Care. 2016 Feb;39(2):179–186. PubMed PMID: 26798148; PubMed Central PMCID: PMCPMC5317235.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. Reducing risks for mental disorders: frontiers for preventive intervention research. Washington, DC: The National Academies Press; 1994. English. (Mrazek PJ, Haggerty RJ, editors.).
   Google Scholar
• Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008 May 24;336(7654):1180–1185. PubMed PMID: 18426840; PubMed Central PMCID: PMCPMC2394709.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research G. Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program. Diabetes Care. 2005 Jan;28(1):138–144. PubMed PMID: 15616247; PubMed Central PMCID: PMCPMC1314971.
   PubMed Web of Science ®Google Scholar
• Benjamin SM, Valdez R, Geiss LS, et al. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care. 2003 Mar;26(3):645–649. PubMed PMID: 12610015.
   PubMed Web of Science ®Google Scholar
• Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015 Sep 08;314(10):1021–1029. PubMed PMID: 26348752.
   PubMed Web of Science ®Google Scholar
• Ackermann RT, Cheng YJ, Williamson DF, et al. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c national health and nutrition examination survey 2005–2006. Am J Prev Med. 2011 Jan;40(1):11–17. PubMed PMID: 21146762.
   PubMed Web of Science ®Google Scholar
• Ackermann RT, Finch EA, Brizendine E, et al. Translating the Diabetes Prevention Program into the community. The deploy pilot study. Am J Prev Med. 2008 Oct;35(4):357–363. PubMed PMID: 18779029; PubMed Central PMCID: PMCPMC2610485.
   PubMed Web of Science ®Google Scholar
• World Health Organization Chronic Respiratory Diseases and Arthritis Team. Screening for type 2 diabetes: report of a World Health Organization and International Diabetes Federation meeting. World Health Organization Chronic Respiratory Diseases and Arthritis Team, editor. Geneva: World Health Organization; 2003:1-48.
   Google Scholar
• Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006 Sep;29(9):2102–2107. PubMed PMID: 16936160; PubMed Central PMCID: PMCPMC1762038.
   PubMed Web of Science ®Google Scholar
• Glanz K, Bishop DB. The role of behavioral science theory in development and implementation of public health interventions. Annu Rev Public Health. 2010;31:399–418. PubMed PMID: 20070207.
   PubMed Web of Science ®Google Scholar
• Garay-Sevilla ME, Malacara JM, Gutierrez-Roa A, et al. Denial of disease in type 2 diabetes mellitus: its influence on metabolic control and associated factors. Diabet Med. 1999 Mar;16(3):238–244. PubMed PMID: 10227570.
   PubMed Web of Science ®Google Scholar
• Rejeski WJ, Williamson DA. Effects of lifestyle interventions on health related quality of life and physical function. In: editors, Wadden TA, Bray GA. Handbook of obesity treatment. Vol. 2. New York: Guilford Press. 2018. p. 223-240.
   Google Scholar
• Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of weight-loss interventions in adults with prediabetes: a review. Am J Prev Med. 2005 Jan;28(1):126–139. PubMed PMID: 15626569.
   PubMed Web of Science ®Google Scholar
• The Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012 Apr;35(4):723–730. PubMed PMID: 22442395; PubMed Central PMCID: PMCPMC3308273.
   PubMed Web of Science ®Google Scholar
• Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med. 2004 Feb;58(4):851–862. PubMed PMID: 14672598.
   PubMed Web of Science ®Google Scholar
• LaRose JG, Leahey TM, Hill JO, et al. Differences in motivations and weight loss behaviors in young adults and older adults in the National Weight Control Registry. Obesity. (Silver Spring). 2013Mar;21(3);449–453 PubMed PMID: 23404944; PubMed Central PMCID: PMCPMC3630273
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu G, Zhang L, et al. A novel testing model for opportunistic screening of prediabetes and diabetes among U.S. adults. PLoS One. 2015;10(3):e0120382. PubMed PMID: 25790106; PubMed Central PMCID: PMCPMC4366186.
   PubMed Web of Science ®Google Scholar
• Loveman E, Frampton GK, Shepherd J, et al. The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess. 2011 Jan;15(2):1–182. PubMed PMID: 21247515; PubMed Central PMCID: PMCPMC4781196.
   Web of Science ®Google Scholar
• Horstman C, Aronne L, Wing R, et al. Implementing an online weight management intervention to an employee population: initial experience with real appeal®. Obesity. in press.
   Web of Science ®Google Scholar